Product Code: ETC417485 | Publication Date: Oct 2022 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the UK, the corticosteroids market is primarily driven by their extensive use in treating inflammatory conditions, allergies, and autoimmune disorders. Pharmaceutical advancements, coupled with rising incidences of chronic diseases, contribute to market growth. Regulatory approvals, patent expirations, and healthcare expenditure trends significantly influence market dynamics.
In the UK, the corticosteroids market is influenced by rising incidences of chronic diseases such as asthma, arthritis, and allergies, which necessitate effective anti-inflammatory treatments. Corticosteroids are pivotal in managing these conditions, driving demand among healthcare providers and patients alike. The market also benefits from ongoing research and development efforts aimed at enhancing drug efficacy and reducing side effects associated with prolonged corticosteroid use. Moreover, aging populations and increasing healthcare expenditures contribute to sustained market growth as corticosteroids remain integral to therapeutic regimens across various medical specialties.
The UK corticosteroids market faces challenges shaped by regulatory reforms, pricing pressures, and clinical efficacy expectations. Regulatory changes in drug approvals and pricing policies impact market access and profitability for manufacturers. Additionally, the emergence of generic alternatives and biosimilars intensifies competition, driving down prices and squeezing profit margins. Moreover, the demand for novel formulations and therapeutic innovations necessitates substantial R&D investments, posing financial constraints on market players. Adapting to these challenges requires strategic partnerships, portfolio diversification, and compliance with stringent regulatory standards to sustain market leadership and meet patient needs effectively.
The UK corticosteroids market is impacted by pharmaceutical regulations and healthcare policies. Government policies govern drug approvals, pricing regulations, and reimbursement schemes under the National Health Service (NHS). Regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA) oversee compliance with safety standards and clinical efficacy requirements.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Corticosteroids Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Corticosteroids Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Corticosteroids Market - Industry Life Cycle |
3.4 United Kingdom (UK) Corticosteroids Market - Porter's Five Forces |
3.5 United Kingdom (UK) Corticosteroids Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United Kingdom (UK) Corticosteroids Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Corticosteroids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Kingdom (UK) Corticosteroids Market Trends |
6 United Kingdom (UK) Corticosteroids Market, By Types |
6.1 United Kingdom (UK) Corticosteroids Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.1.4 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Rhuematology Indications, 2021-2031F |
6.1.5 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.6 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.1.7 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
6.2 United Kingdom (UK) Corticosteroids Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Hospitals, 2021-2031F |
6.2.3 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.4 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Research Institutes, 2021-2031F |
6.2.5 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
7 United Kingdom (UK) Corticosteroids Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Corticosteroids Market Export to Major Countries |
7.2 United Kingdom (UK) Corticosteroids Market Imports from Major Countries |
8 United Kingdom (UK) Corticosteroids Market Key Performance Indicators |
9 United Kingdom (UK) Corticosteroids Market - Opportunity Assessment |
9.1 United Kingdom (UK) Corticosteroids Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United Kingdom (UK) Corticosteroids Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Corticosteroids Market - Competitive Landscape |
10.1 United Kingdom (UK) Corticosteroids Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Corticosteroids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |